Literature DB >> 16870183

NF1 mRNA biogenesis: effect of the genomic milieu in splicing regulation of the NF1 exon 37 region.

Marco Baralle1, Natasa Skoko, Anna Knezevich, Laura De Conti, Dario Motti, Madhuri Bhuvanagiri, Diana Baralle, Emanuele Buratti, Francisco E Baralle.   

Abstract

We have studied the splicing regulation of NF1 exons 36 and 37. We show that they not only require an intact exonic Splicing Enhancer (ESE) within exon 37, but also need the genomic region stretching from exons 31 to 38. Any nucleotide change in two exon 37 third codon positions disrupts the ESE. The extent of exons 36 and 37 skipping due to a mutated ESE depends on the genomic context. This is a unique example of what may be a more general phenomena involved in the tuning of pre-mRNA processing and gene expression modulation in the chromosomal setting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16870183     DOI: 10.1016/j.febslet.2006.07.018

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

Review 1.  Missed threads. The impact of pre-mRNA splicing defects on clinical practice.

Authors:  Diana Baralle; Anneke Lucassen; Emanuele Buratti
Journal:  EMBO Rep       Date:  2009-08       Impact factor: 8.807

2.  Experimental assessment of splicing variants using expression minigenes and comparison with in silico predictions.

Authors:  Neeraj Sharma; Patrick R Sosnay; Anabela S Ramalho; Christopher Douville; Arianna Franca; Laura B Gottschalk; Jeenah Park; Melissa Lee; Briana Vecchio-Pagan; Karen S Raraigh; Margarida D Amaral; Rachel Karchin; Garry R Cutting
Journal:  Hum Mutat       Date:  2014-09-10       Impact factor: 4.878

3.  Splicing defects caused by exonic mutations in PKD1 as a new mechanism of pathogenesis in autosomal dominant polycystic kidney disease.

Authors:  Felix Claverie-Martin; Francisco J Gonzalez-Paredes; Elena Ramos-Trujillo
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

4.  Abnormal mitoferrin-1 expression in patients with erythropoietic protoporphyria.

Authors:  Yongming Wang; Nathaniel B Langer; George C Shaw; Guang Yang; Liangtao Li; Jerry Kaplan; Barry H Paw; Joseph R Bloomer
Journal:  Exp Hematol       Date:  2011-05-11       Impact factor: 3.084

Review 5.  The pathoetiology of neurofibromatosis 1.

Authors:  Eeva-Mari Jouhilahti; Sirkku Peltonen; Anthony M Heape; Juha Peltonen
Journal:  Am J Pathol       Date:  2011-03-31       Impact factor: 4.307

6.  Genomic features defining exonic variants that modulate splicing.

Authors:  Adam Woolfe; James C Mullikin; Laura Elnitski
Journal:  Genome Biol       Date:  2010-02-16       Impact factor: 13.583

7.  Modulation of aberrant NF1 pre-mRNA splicing by kinetin treatment.

Authors:  Eva Pros; Juana Fernández-Rodríguez; Llúcia Benito; Anna Ravella; Gabriel Capellá; Ignacio Blanco; Eduard Serra; Conxi Lázaro
Journal:  Eur J Hum Genet       Date:  2009-11-25       Impact factor: 4.246

8.  Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene.

Authors:  Takehito Tsuji; Kaoru Yamada; Tetsuo Kunieda
Journal:  Mamm Genome       Date:  2009-09-16       Impact factor: 2.957

9.  The intronic splicing code: multiple factors involved in ATM pseudoexon definition.

Authors:  Ashish Dhir; Emanuele Buratti; Maria A van Santen; Reinhard Lührmann; Francisco E Baralle
Journal:  EMBO J       Date:  2010-01-21       Impact factor: 11.598

10.  Propionic and methylmalonic acidemia: antisense therapeutics for intronic variations causing aberrantly spliced messenger RNA.

Authors:  A Rincón; C Aguado; L R Desviat; R Sánchez-Alcudia; M Ugarte; B Pérez
Journal:  Am J Hum Genet       Date:  2007-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.